Inventor

YU DONG

US295 patents

⚠️ This page may combine multiple inventors who share the name “YU DONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YU DONG

IDERA PHARMACEUTICALS INC

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Immunostimulatory oligonucleotide multimers

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides

Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents

Immunostimulatory oligonucleotide multimers

Immunostimulatory oligonucleotide multimers

Immunostimulatory oligonucleotide multimers

Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides

Immunostimulatory oligonucleotide multimers

Short immunomodulatory oligonucleotides

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Synthetic agonists of TLR9

Stabilized immunomodulatory oligonucleotides

Synthetic agonists of TLR9

MICROSOFT CORP

Exploiting heterogeneous data in deep neural network-based speech recognition systems

System and method for identifying semantic intent from acoustic information

Multilingual deep neural network

Mixed speech recognition

Integrated speech recognition and semantic classification

System and method for user modeling to enhance named entity recognition

Deep neural networks training for speech and pattern recognition

Automatic speech recognition learning using user corrections

NANOSOLAR INC

Solution-based fabrication of photovoltaic cell

Coated nanoparticles and quantum dots for solution-based fabrication of photovoltaic cells

Molding technique for fabrication of optoelectronic devices

Optoelectronic device and fabrication method

Nanostructured layer and fabrication methods

HYBRIDON INC

Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same

Synthesis of oligonucleotides containing alkylphosphonate internucleoside linkages

Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages

5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses

Base protecting groups and synthons for oligonucleotide synthesis

YU DONG

Speech-centric multimodal user interface design in mobile technology

Microwave brewing apparatus and method

Exploiting sparseness in training deep neural networks

MICROSOFT TECHNOLOGY LICENSING LLC

Permutation invariant training for talker-independent multi-talker speech separation

Multi-speaker speech separation

Low-footprint adaptation and personalization for a deep neural network

AGRAWAL SUDHIR

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Compositions for inhibiting gene expression and uses thereof

TENCENT TECH SHENZHEN CO LTD

Knowledge transfer in permutation invariant training for single-channel multi-talker speech recognition

NANOSULAR INC

Photovoltaic devices fabricated by growth from porous template

KANDIMALLA EKAMBAR

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS

Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides